Newer gadolinium-based contrast agents offer potential advantages in high-dose or dynamic imaging due to lower osmolality. Current standard doses show no significant clinical differences in efficacy or safety among available agents.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: